Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus.
Chang CP, Yeh TK, Chen CT, Wang WP, Chen YT, Tsai CH, Chen YF, Ke YY, Wang JY, Chen CP, Hsieh TC, Wu MH, Huang CL, Chen YP, Zhuang H, Chi YH.
Chang CP, et al. Among authors: yeh tk.
Mol Cancer Ther. 2024 Jun 4;23(6):766-779. doi: 10.1158/1535-7163.MCT-23-0602.
Mol Cancer Ther. 2024.
PMID: 38592383